Recommendations when to order or not order the test. May include related or preferred tests.
Aids in the detection and subclassification of hyperandrogenism. Most useful in women and children with moderate/severe hirsutism or hirsutism of any degree when it is sudden in onset or rapidly progressive.
Mnemonic
Unique test identifier.
HIRSUTISM
Methodology
Process(es) used to perform the test.
Quantitative Chemiluminescent Immunoassay/Electrochemiluminescent Immunoassay/Liquid Chromatography-Tandem Mass Spectrometry
Performed
Days of the week the test is performed.
Sun, Tue-Fri
Reported
Expected turnaround time for a result, beginning when ARUP has received the specimen.
1-4 days
New York DOH Approval Status
Indicates test has been approved by the New York State Department of Health.
This test is New York DOH approved.
Specimen Required
Patient Preparation
Collect between 6-10 a.m.
Collect
Serum separator tube.
Specimen Preparation
Separate serum from cells ASAP or within 2 hours of collection. Transfer 2.5 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 1.5 mL)
Storage/Transport Temperature
Frozen.
Unacceptable Conditions
Hemolyzed specimens.
Remarks
Stability
After separation from cells: Ambient: 2 hours; Refrigerated: 48 hours; Frozen: 2 months
Reference Interval
Normal range/expected value(s) for a specific disease state. May also include abnormal ranges.
Test Number
Components
Reference Interval
DHEAS
Age
Male (ug/dL)
Female (ug/dL)
0-6 days
108-607
108-607
7-30 days
32-431
32-431
1-5 months
3-124
3-124
6-35 months
0-33
0-29
3-6 years
0-44
0-47
7-9 years
5-115
5-94
10-14 years
22-332
22-255
15-19 years
88-483
63-373
20-24 years
211-492
148-407
25-34 years
160-449
99-340
35-44 years
89-427
61-337
45-54 years
44-331
35-256
55-64 years
52-295
19-205
65-74 years
34-249
9-246
75 years and older
16-123
12-154
Tanner Stage I
7-209
7-126
Tanner Stage II
28-260
13-241
Tanner Stage III
39-390
32-446
Tanner Stage IV & V
81-488
65-371
Testosterone by Mass Spec
Age
Male (ng/dL)
Female (ng/dL)
Premature (26-28 weeks)
59-125
5-16
Premature (31-35 weeks)
37-198
5-22
Newborn
75-400
20-64
1-5 months
14-363
Less than 20
6-24 months
Less than 37
Less than 9
2-3 years
Less than 15
Less than 20
4-5 years
Less than 19
Less than 30
6-7 years
Less than 13
Less than 7
8-9 years
2-8
1-11
10-11 years
2-165
3-32
12-13 years
3-619
6-50
14-15 years
31-733
6-52
16-17 years
158-826
9-58
18-39 years
300-1080
9-55
40-59 years
300-890
9-55
60 years and older
300-720
5-32
Premenopausal (18 years and older)
Not Applicable
9-55
Postmenopausal
Not Applicable
5-32
Tanner Stage I
2-15
2-17
Tanner Stage II
3-303
5-40
Tanner Stage III
10-851
10-63
Tanner Stage IV-V
162-847
11-62
Testosterone, Free by Mass Spec
Age
Male (pg/mL)
Female (pg/mL)
1-6 years
Less than 0.6
Less than 0.6
7-9 years
0.1-0.9
0.6-1.8
10-11
0.1-6.3
0.1-3.5
12-13
0.5-98.0
0.9-6.8
14-15
3-138.0
1.2-7.5
16-17
38.0-173.0
1.2-9.9
18 years and older
47-244
Not Applicable
18-30
Not Applicable
0.8-7.4
31-40
Not Applicable
1.3-9.2
41-51
Not Applicable
1.1-5.8
Postmenopausal
Not Applicable
0.6-3.8
Tanner Stage I
Less than or equal to 3.7
Less than 2.2
Tanner Stage II
0.3-21
0.4-4.5
Tanner Stage III
1.0-98.0
1.3-7.5
Tanner Stage IV
35.0-169.0
1.1-15.5
Tanner Stage V
41.0-239.0
0.8-9.2
Sex Hormone Binding Globulin
Age
Male (nmol/L)
Female (nmol/L)
1-30 days
13-85
14-60
31-364 days
70-250
60-215
1-3 years
50-180
60-190
4-6 years
45-175
55-170
7-9 years
28-190
35-170
10-12 years
23-160
17-155
13-15 years
13-140
11-120
16-17 years
10-60
19-145
18-49 years
17-56
25-122
50 years and older
19-76
17-125
Tanner Stage I
26-186
30-173
Tanner Stage II
22-169
16-127
Tanner Stage III
13-104
12-98
Tanner Stage IV
11-60
14-151
Tanner Stage V
11-71
23-165
Androstenedione by TMS
Age
Male (ng/mL)
Female (ng/mL)
Premature Infants (26-28 weeks Day 4)
0.92-2.82
0.92-2.82
Premature Infants (31-35 weeks Day 4)
0.80-4.46
0.80-4.46
Full Term Infants (1-7 days)
0.20-2.90
0.20-2.90
8-30 days
0.18-0.80
0.18-0.80
1-5 months
0.06-0.68
0.06-0.68
6-24 months
0.03-0.15
Less than 0.15
2-3 years
Less than 0.11
Less than 0.16
4-5 years
0.02-0.17
0.02-0.21
6-7 years
0.01-0.29
0.02-0.28
8-9 years
0.03-0.30
0.04-0.42
10-11 years
0.07-0.39
0.09-1.23
12-13 years
0.10-0.64
0.24-1.73
14-15 years
0.18-0.94
0.39-2.00
16-17 years
0.30-1.13
0.35-2.12
18-39 years
0.33-1.34
0.26-2.14
40 years and older
0.23-0.89
0.13-0.82
Premenopausal
Not Applicable
0.26-2.14
Postmenopausal
Not Applicable
0.13-0.82
Tanner Stage I
0.04-0.32
0.05-0.51
Tanner Stage II
0.08-0.48
0.15-1.37
Tanner Stage III
0.14-0.87
0.37-2.24
Tanner Stage IV-V
0.27-1.07
0.35-2.05
Interpretive Data
Background information for test. May include disease information, patient result explanation, recommendations, details of testing, associated diseases, explanation of possible patient results.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
The American Medical Association Current Procedural Terminology (CPT) codes published in ARUP's Laboratory Test Directory are provided for informational purposes only. The codes reflect our interpretation of CPT coding requirements based upon AMA guidelines published annually. CPT codes are provided only as guidance to assist clients with billing. ARUP strongly recommends that clients confirm CPT codes with their Medicare administrative contractor, as requirements may differ. CPT coding is the sole responsibility of the billing party. ARUP Laboratories assumes no responsibility for billing errors due to reliance on the CPT codes published.
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Chat
Feedback
